| Literature DB >> 26482908 |
Cathriona Foley1,2, Aspinas Chapwanya3, John J Callanan3,4, Ronan Whiston1,2, Raúl Miranda-CasoLuengo5, Junnan Lu5, Wim G Meijer5, David J Lynn1,6,7, Cliona O' Farrelly2, Kieran G Meade8.
Abstract
BACKGROUND: The regulation of endometrial inflammation has important consequences for the resumption of bovine fertility postpartum. All cows experience bacterial influx into the uterus after calving; however a significant proportion fail to clear infection leading to the development of cytological endometritis (CE) and compromised fertility. We hypothesised that early immunological changes could not only act as potential prognostic biomarkers for the subsequent development of disease but also shed light on the pathogenesis of endometritis in the postpartum dairy cow.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26482908 PMCID: PMC4617749 DOI: 10.1186/s12864-015-1967-5
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Histological Analysis of Biospies Acccording to Leukocyte Infiltration into the Epithelial and Stromal Layers of the Uterus. a and c Representative histological classification of endometrial biopsies at 7 DPP shows significant immune cell infiltrate. b This influx of leukocytes is not apparent in HC cows, which have resolved inflammation by 21 DPP. d Cows that develop CE however, have sustained immune cell infiltrate in the endometrium at 21 DPP. Magnification shown in 400×
Fig. 2Next-Generation Sequencing (NGS) of messenger RNA from Uterine Biopsies at both 7 and 21 DPP. a top panel High numbers of genes are differentially expressed in the endometrium from the HC (healthy) group between 7 and 21 DPP, whereas (bottom panel) the same transition in gene expression profile between time points is not present in cows that develop CE. The numbers of significantly differentially expressed genes between groups at both postpartum time points are shown (FDR < 0.1). Within group comparisons are shown in red boxes, and between group comparisons are in blue boxes. The numbers in green ovals show the direction in relative gene expression between comparisons. b MDS plots generated from endometrial RNA-seq data shows clearer clustering of 7 and 21 DPP time points for the HC group (top panel) than for the CE group (bottom panel). Nine HC (healthy control) endometrial samples at both 7 DPP (red) and corresponding same animal sample at 21 DPP (green) and b six CE (cytologically endometritic) cows at the same two time points are shown. Corresponding gene lists are shown in Additional file 2: Table S2
Top 10 DEG (FDR >0.01) between HC and CE samples at 7 DPP
| Gene symbol | Ensembl ID | Gene name | log2 FC | FDR |
|---|---|---|---|---|
| Increased in CE at 7DPP | ||||
|
| ENSBTAG00000012467 | Mannose-associated serine protease 1 | 1.86 | 0.001764 |
|
| ENSBTAG00000040394 | Protease, serine 27 | 4.69 | 0.001764 |
|
| ENSBTAG00000001925 | Transmembrane protease, serine 11D | 5.02 | 0.002132 |
|
| ENSBTAG00000037800 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | 4.10 | 0.002193 |
|
| ENSBTAG00000038520 | - | 4.74 | 0.002193 |
|
| ENSBTAG00000046544 | Solute carrier family 7, member 10 | 3.53 | 0.002492 |
|
| ENSBTAG00000006282 | POU class 2 associating factor 1 | 3.67 | 0.002819 |
| Increased in HC at 7DPP | ||||
|
| ENSBTAG00000021310 | Collagen, type IV, alpha 4 | 2.95 | 0.000950 |
|
| ENSBTAG00000021118 | Cytochrome P450, family 26, subfamily a, polypeptide 1 | 4.75 | 0.001764 |
|
| ENSBTAG00000003253 | Natriuretic peptide C | 3.56 | 0.002193 |
DEG miRNA 7DPP between groups (log2 FC >1.5)
| miRNA name | Ensembl ID | log2 FC | FDR |
|---|---|---|---|
| Increased in CE at 7 DPP | |||
| bta-let-7c | ENSBTAG00000029912 | 1.8 | 0.050435 |
| bta-mir-31 | ENSBTAG00000047544 | 2.0 | 0.014096 |
| bta-mir-34b | ENSBTAG00000029856 | 2.4 | 0.0257 |
| bta-mir-96 | ENSBTAG00000029977 | 1.7 | 0.014096 |
| bta-mir-144 | ENSBTAG00000029953 | 1.6 | 0.064382 |
| bta-mir-147 | ENSBTAG00000036401 | 1.5 | 0.032079 |
| bta-mir-183 | ENSBTAG00000029762 | 1.5 | 0.036838 |
| bta-mir-197 | ENSBTAG00000029921 | 2.2 | 0.000236 |
| bta-mir-200b | ENSBTAG00000030062 | 1.6 | 0.036952 |
| bta-mir-200c | ENSBTAG00000029959 | 2.1 | 0.012538 |
| bta-mir-205 | ENSBTAG00000029854 | 7.6 | 6.31E-05 |
| bta-mir-375 | ENSBTAG00000029763 | 3.3 | 0.000236 |
| bta-mir-451 | ENSBTAG00000036414 | 2.0 | 0.02058 |
| bta-mir-486 | ENSBTAG00000037264 | 1.9 | 0.014096 |
| Increased in HC at 7 DPP | |||
| bta-mir-424 | ENSBTAG00000036419 | 2.1 | 0.012538 |
| bta-mir-450b | ENSBTAG00000043695 | 1.8 | 0.043424 |
| bta-mir-542 | ENSBTAG00000030024 | 1.8 | 0.0257 |
Fig. 3Top 10 Significantly Enriched Biological Processes in the Endometrium Identified by Gene Ontological Analysis. Using significantly differentially expressed gene datasets, gene ontology analysis identifed the enriched biological processes (a) in HC cows between 7 and 21 DPP and b between HC and CE samples at 21 DPP. The resolution of the inflammatory response in HC cows (a) is evident as these defence and innate immune response processes are switched off. The sustained inflammatory response (lack of transition) is evident in (b) as these processes are enriched in CE compared to HC at 21 DPP. For full list of enriched gene ontologies, see Additional file 4: Table S4
Significantly DEG (Log2 FC >1.3, FDR >0.1) in HC samples between 7 and 21 DPP
| Gene symbol | Ensembl ID | Gene name | log2 FC | FDR |
|---|---|---|---|---|
| Complement proteins | ||||
|
| ENSBTAG00000016204 | Complement component 1, r subcomponent-like | 1.69 | 0.000165996 |
|
| ENSBTAG00000007450 | Complement component 2 | 2.67 | 2.08E-11 |
|
| ENSBTAG00000017280 | Complement component 2 | 1.94 | 0.002331252 |
|
| ENSBTAG00000019741 | Complement component 3a receptor 1 | 2.25 | 7.41E-08 |
|
| ENSBTAG00000009876 | Complement component 4 binding protein, alpha | 3.10 | 0.002072385 |
|
| ENSBTAG00000020872 | Complement component 5a receptor 1 | 2.87 | 3.30E-12 |
|
| ENSBTAG00000016149 | Complement component 9 | 1.94 | 0.094234244 |
| Cell surface receptors | ||||
|
| ENSBTAG00000009421 | CD1e molecule | 2.02 | 9.19E-07 |
|
| ENSBTAG00000015032 | CD14 molecule | 3.16 | 8.72E-26 |
|
| ENSBTAG00000017866 | CD36 molecule | 2.43 | 5.47E-15 |
|
| ENSBTAG00000020736 | CD40 molecule | 1.53 | 0.000643093 |
|
| ENSBTAG00000000133 | CD68 molecule | 2.79 | 3.49E-12 |
|
| ENSBTAG00000031430 | CD83 molecule | 1.53 | 4.91E-05 |
|
| ENSBTAG00000019033 | CD84 molecule | 2.23 | 5.98E-06 |
|
| ENSBTAG00000013118 | CD86 molecule | 2.54 | 3.55E-11 |
|
| ENSBTAG00000019669 | CD163 molecule | 3.37 | 6.04E-13 |
|
| ENSBTAG00000001235 | CD200 receptor 1 | 1.68 | 0.000161784 |
|
| ENSBTAG00000007312 | CD209 molecule | 2.11 | 0.000602415 |
|
| ENSBTAG00000004690 | CD300e molecule | 2.51 | 6.68E-08 |
| Pathogen recognition receptors | ||||
|
| ENSBTAG00000006572 | Caspase recruitment domain family, member 9 | 1.75 | 9.21E-07 |
|
| ENSBTAG00000015261 | Caspase recruitment domain family, member 14 | 1.63 | 1.05E-05 |
|
| ENSBTAG00000008008 | Toll-like receptor 2 | 2.51 | 1.52E-10 |
|
| ENSBTAG00000006240 | Toll-like receptor 4 | 1.38 | 5.54E-08 |
|
| ENSBTAG00000022161 | Toll-like receptor 7 | 2.41 | 3.28E-07 |
|
| ENSBTAG00000020433 | NLR family, pyrin domain containing 1 | 1.68 | 2.14E-06 |
| Chemokine ligands and receptors | ||||
|
| ENSBTAG00000037811 | Chemokine (C-C motif) ligand 2 | 2.20 | 0.000317988 |
|
| ENSBTAG00000014113 | Chemokine (C-C motif) ligand 8 | 2.03 | 0.003473125 |
|
| ENSBTAG00000021326 | Chemokine (C-C motif) ligand 20 | 2.25 | 0.031650056 |
|
| ENSBTAG00000019428 | Chemokine (C-C motif) receptor 1 | 2.65 | 2.78E-10 |
|
| ENSBTAG00000037778 | Chemokine (C-X-C motif) ligand 3 | 2.52 | 0.000160609 |
|
| ENSBTAG00000009812 | Chemokine (C-X-C motif) ligand 6 | 3.28 | 0.001050477 |
|
| ENSBTAG00000038639 | Chemokine (C-X-C motif) ligand 9 | 1.95 | 0.011169775 |
|
| ENSBTAG00000026753 | Chemokine (C-X-C motif) receptor 2 | 2.62 | 0.032556379 |
|
| ENSBTAG00000006694 | Chemokine (C-X-C motif) ligand 14 | 1.89 | 0.000337958 |
|
| ENSBTAG00000018652 | Chemokine (C-X-C motif) ligand 17 | 2.82 | 0.008009971 |
| Cytokines and receptors | ||||
|
| ENSBTAG00000010349 | Interleukin 1 alpha | 2.66 | 0.016846664 |
|
| ENSBTAG00000005273 | Interleukin 1 receptor, type 1 | 1.59 | 0.00014519 |
|
| ENSBTAG00000006343 | Interleukin 1 receptor, type 2 | 4.85 | 3.97E-07 |
|
| ENSBTAG00000018571 | Interleukin 1 receptor-like 1 | 4.33 | 0.000262878 |
|
| ENSBTAG00000014921 | Interleukin 6 | 5.88 | 2.78E-06 |
|
| ENSBTAG00000005215 | Interleukin 10 receptor, alpha | 1.73 | 9.19E-06 |
|
| ENSBTAG00000001034 | Interleukin 18 receptor 1 | 1.85 | 0.002233603 |
|
| ENSBTAG00000001100 | Interleukin 22 receptor, alpha 1 | 2.35 | 7.33E-06 |
|
| ENSBTAG00000025471 | Tumor necrosis factor | 1.43 | 0.007893141 |
| Antimicrobial peptides | ||||
|
| ENSBTAG00000045649 | Defensin, beta | 2.33 | 0.008979282 |
|
| ENSBTAG00000034954 | Defensin, beta 5 | 2.63 | 0.000491966 |
|
| ENSBTAG00000045626 | Beta-defensin 103B-like | 2.96 | 0.028072666 |
|
| ENSBTAG00000037651 | S100 calcium binding protein A2 | 2.19 | 1.75E-06 |
|
| ENSBTAG00000000644 | S100 calcium binding protein A5 | 3.22 | 1.07E-12 |
|
| ENSBTAG00000012640 | S100 calcium binding protein A8 | 2.99 | 0.00064399 |
|
| ENSBTAG00000006505 | S100 calcium binding protein A9 | 3.46 | 7.83E-05 |
|
| ENSBTAG00000012638 | S100 calcium binding protein A12 | 2.99 | 4.98E-05 |
| Acute phase proteins | ||||
|
| ENSBTAG00000006354 | Haptoglobin | 2.40 | 0.041554479 |
|
| ENSBTAG00000016864 | Lipopolysaccharide binding protein | 2.92 | 0.000384619 |
|
| ENSBTAG00000010433 | Mammary serum amyloid A3.2 | 1.44 | 0.012854981 |
|
| ENSBTAG00000022394 | Serum amyloid A1 | 3.67 | 0.000142222 |
|
| ENSBTAG00000022396 | Serum amyloid A3 | 1.99 | 0.002751998 |
|
| ENSBTAG00000007273 | Transferrin | 3.12 | 1.56E-12 |
Fig. 4The Kyoto Encyclopaedia of Genes and Genomes (KEGG) annotated the Toll-Like Receptor Signalling Pathway as significantly enriched in the RNA-seq dataset for HC. Green boxes highlight the genes within the pathway that are significantly elevated in expression 7 DPP. For other significantly enriched pathways see Figure S1 (NFkB Signalling Pathway) and Figure S2 (Cytokine-cytokine receptor interaction). For full list of differentially expressed pathways see also Additional file 3: Table S3
Fig. 5Heat map representation depicting the temporal changes in significantly differentially expressed genes from uterine biopsies between 7 and 21 DPP in the a HC and b CE cows. All 31 significantly DEGs were used to generate the heatmap in the CE group, and a similar number of the top DEGs (ranked on basis of P value) were used for comparative purposes for the HC group. Scale: Yellow indicates high expression and red is low expression. Unsupervised hierarchical clustering dendograms are included for these genes. a – DE genes between day 7 and 21 DPP in HC animals and b – DE genes between day 7 and 21 DPP in CE cows
Fig. 6RT-qPCR validation of gene expression changes detected using mRNA-seq. Confirmation of differentially expressed genes from NGS results using quantitative real-time PCR. Significant changes in gene expression of both a pro- and anti-inflammatory cytokines as well as other b effector molecules of the immune response confirmed the findings from NGS. Results are colour-coded according to comparison and levels of expression of each gene of interest was normalised to expression levels of PPIA; D7PP between SCE and HC cows (black), D21PP between SCE and HC (blue), between D7 and D21PP in SCE (red) and between D7 and D21PP in HC (green). Between and within group comparisons are separated by a dotted line. *P < 0.05; **P < 0.01. n = 5–8 samples per time point, bars represent mean ± SEM
Fig. 7Multi-Dimensional Scaling (MDS) Plots Generated from Endometrial microRNA-seq Data. a MDS-plot shown for HC cows at both 7 (red) and 21 DPP (green). Similarly, b MDS-plot shown for CE cows at both 7 (red) and 21 DPP (green). Clustering of the D7 and D21 profiles is apparent at both time points for HC and CE cows although tighter clustering of 7 DPP samples for the HC group than for the CE group (b) shows a higher degree of variation between samples at 7 DPP (b, red). Five HC (healthy control) samples at both 7 DPP (D7, red) and corresponding same animal sample at 21 DPP (D21, green) and B) five CE (cytologically endometritic) cows at the same two time points are shown
Fig. 8Principal Coordinates Ordination of Endometrial Bacterial Communities. Bacterial community analysis, performed using culture-independent Terminal Restriction Fragment Length Polymorphism (T-RFLP), shows a significant clustering of samples according to their respective microbial communities. HC and CE cows are shown as blue and red circles, respectively
Fig. 9Analysis of Systemic Immune and Metabolite Parameters in HC and CE cows. Significant early reductions in circulating granulocyte numbers in cows that subsequently developed CE. Absolute cell counts in Peripheral blood leukocytes (PBL) for a neutrophils and b eosinophils. Elevated plasma expression levels for c Haptoglobin (HP), d Serum Amyloid A (SAA) but not e Interleukin 6 (IL-6) were also detected in cows with CE. No significant differences in serum metabolite profile for f β-hydroxybutyrate (BHB), g non-esterified fatty acids (NEFA) and h Urea between cows that developed CE and HC, although temporal changes were significantly changed. Samples labelled as PC (pre-calving), and at 7 and 21 DPP in HC and CE cows.*P < 0.05; **P < 0.01. n = 5–9 samples per timepoint and bars represent mean ± SEM